You have no items in your shopping cart.
Human BCMA
Description
Images & Validation
−
Key Properties
−| Expression System | Human Cells |
|---|---|
| Biological Origin | Human |
| Biological Activity | ELISA: Immobilized Human BCMA-His-Flag(Cat#orb2993882) at 1μg/ml (100 μl/well)can bind Human BAFF-Fc(Cat#orb2994098).The ED50 of Human BAFF-Fc(Cat#orb2994098) is 13.62 ng/ml. |
| Tag | N-6His-Flag |
| Molecular Weight | Predicted: 7.7 KDa. Observed: (11-14)&(16-26) KDa, reducing conditions |
| Expression Region | Met1-Ala54 |
| Purity | SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. |
| Endotoxins | < 1 EU/µg as determined by LAL test. |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
|---|---|
| Form/Appearance | Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4. |
| Reconstitution | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Human Tumor Necrosis Factor Receptor Superfamily, Member 17 (TNFRSF17) ELISA Kit [orb1817288]
Human
0.16-10 ng/mL
0.071 ng/mL
48 T, 96 TFITC-Labeled Human BCMA [orb2992829]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 9.6 KDa. Observed: 15&16-19 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μgHuman BCMA [orb2994062]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 32.5 KDa. Observed: 35-42 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μgMouse BCMA [orb2994112]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 32.1 KDa. Observed: 35-45 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μgCynomolgus BCMA [orb2994273]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 33.1 KDa. Observed: 38-45 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Quick Database Links
UniProt Details
−Documents Download
Request a Document
Protocol Information
Human BCMA (orb2993882)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review